Stockscreener 앱 받기
17.36
2.66%
0.45
시간 외 거래:
17.27
-0.09
-0.52%
전일 마감가:
$16.91
열려 있는:
$16.9
하루 거래량:
1.91M
Relative Volume:
0.98
시가총액:
$2.64B
수익:
$205.22M
순이익/손실:
$-121.24M
주가수익비율:
-21.32
EPS:
-0.8141
순현금흐름:
$-82.81M
1주 성능:
+0.81%
1개월 성능:
+16.04%
6개월 성능:
+135.87%
1년 성능:
+258.68%
1일 변동 폭
$16.81
$17.76
1주일 범위
$16.59
$17.76
52주 변동 폭
$4.27
$17.89
Adaptive Biotechnologies Corp Stock (ADPT) Company Profile
명칭
Adaptive Biotechnologies Corp
전화
206-659-0067
주소
1165 EASTLAKE AVE E, SEATTLE, WA
ADPT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ADPT
Adaptive Biotechnologies Corp
|
17.36 | 2.57B | 205.22M | -121.24M | -82.81M | -0.8141 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Adaptive Biotechnologies Corp Stock (ADPT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-30 | 개시 | Guggenheim | Buy |
| 2025-06-18 | 개시 | Craig Hallum | Buy |
| 2025-03-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-12-21 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-08-25 | 개시 | Credit Suisse | Underperform |
| 2022-06-03 | 개시 | Piper Sandler | Neutral |
| 2022-02-16 | 재확인 | BTIG Research | Buy |
| 2022-02-16 | 재확인 | BofA Securities | Buy |
| 2022-02-16 | 재확인 | Goldman | Neutral |
| 2022-02-16 | 재확인 | JP Morgan | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-03-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-10-08 | 재개 | BTIG Research | Buy |
| 2020-09-09 | 개시 | Morgan Stanley | Equal-Weight |
| 2020-06-03 | 개시 | Goldman | Buy |
| 2019-07-23 | 개시 | BTIG Research | Buy |
| 2019-07-22 | 개시 | BofA/Merrill | Buy |
| 2019-07-22 | 개시 | Cowen | Outperform |
| 2019-07-22 | 개시 | Goldman | Neutral |
| 2019-07-22 | 개시 | Guggenheim | Buy |
| 2019-07-22 | 개시 | William Blair | Outperform |
모두보기
Adaptive Biotechnologies Corp 주식(ADPT)의 최신 뉴스
Using Ichimoku Cloud for Adaptive Biotechnologies Corporation technicalsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
What catalysts could drive Adaptive Biotechnologies Corporation stock higherTake Profit & Daily Profit Focused Stock Screening - newser.com
Can Adaptive Biotechnologies Corporation (1HM) stock expand revenue streamsVolume Spike & Verified Chart Pattern Signals - newser.com
How New Developments Are Shaping Analyst Views on Adaptive Biotechnologies’ Future - Yahoo! Finance Canada
How Adaptive Biotechnologies Corporation stock reacts to oil pricesJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
How Adaptive Biotechnologies Corporation stock compares to industry benchmarksQuarterly Investment Review & AI Forecasted Stock Moves - newser.com
How Adaptive Biotechnologies Corporation stock performs in high volatility marketsPortfolio Performance Report & Consistent Return Investment Signals - newser.com
Why Adaptive Biotechnologies Corporation stock could benefit from AI revolutionGDP Growth & Weekly Market Pulse Alerts - newser.com
Does Adaptive Biotechnologies Corporation fit your quant trading modelPortfolio Gains Summary & Reliable Intraday Trade Alerts - newser.com
Cwm LLC Sells 1,487 Shares of Adaptive Biotechnologies Corporation $ADPT - Defense World
Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release - Yahoo Finance
How Adaptive Biotechnologies Corporation stock trades during market volatilityTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Adaptive Biotechnologies2025 Funding Rounds & List of Investors - Tracxn
Adaptive Biotechnologies (ADPT) Price Target Increased by 17.35% to 16.76 - Nasdaq
What dividend safety score for Adaptive Biotechnologies Corporation stockJuly 2025 Drop Watch & AI Optimized Trading Strategy Guides - newser.com
Technical signs of recovery in Adaptive Biotechnologies Corporation2025 Market Trends & Verified Entry Point Detection - newser.com
Is Adaptive Biotechnologies Corporation stock supported by innovation pipelineGap Down & Comprehensive Market Scan Insights - newser.com
Heatmap analysis for Adaptive Biotechnologies Corporation and competitorsBuy Signal & Expert Approved Trade Ideas - newser.com
Is Adaptive Biotechnologies Corporation stock a contrarian buyBear Alert & Community Consensus Picks - newser.com
How Adaptive Biotechnologies Corporation (1HM) stock performs during market turbulenceTrade Entry Summary & Community Verified Watchlist Alerts - newser.com
Will Adaptive Biotechnologies Corporation stock benefit from upcoming earnings reportsPortfolio Gains Summary & Growth Focused Entry Point Reports - newser.com
Exit strategy if you’re trapped in Adaptive Biotechnologies CorporationPortfolio Risk Summary & Real-Time Volume Trigger Notifications - newser.com
Adaptive Biotechnologies Corp (ADPT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.62%
0.21%
자본화:
|
볼륨(24시간):